May 10 (Reuters) - Revive Therapeutics Ltd RVV.V
* Says will start its Phase 2B trial in gout when it has
access to capital necessary to fund trial
* Over last several months, has taken necessary steps to
reduce its monthly cash burn rate and streamline its operations
Source text for Eikon: ID:nMKWBpdjZa
Further company coverage: RVV.V
(Bengaluru Newsroom: +1 646 223 8780)